BioMelbourne Network
Progressing BioIndustry
Starpharma Limited
Website Address:
http://www.starpharma.com
Corporate Member:
Dr Jackie Fairley
Chief Executive Officer
Company Profile:
Starpharma is a world leader in the development of nanotechnology-based pharmaceuticals and, through its US-based subsidiary Dendritic Nanotechnologies (DNT), a range of life-science and industrial uses.
Starpharma’s lead development candidates are based on dendrimer nanotechnology. Dendrimers are man made, nano-sized compounds with unique properties that make them useful to the health and pharmaceutical industry as both enhancements to existing products and as entirely new products. Dendrimers are constructed by the successive addition of layers to the branching groups. Each new layer is called a generation. The final generation incorporates the surface molecules that give the dendrimer the desired function for medical, electronic, chemical and materials applications.
